Diagnostic performance of controlled attenuation parameter for predicting steatosis grade in chronic hepatitis B

Background & aims. A novel controlled attenuation parameter (CAP) using the signals acquired by the FibroScan® has been developed as a method for evaluating steatosis. The aim of this study is to assess the performance of the CAP for the detection and quantification of steatosis in patients...

Full description

Bibliographic Details
Main Authors: Ana C. Cardoso, Michel Beaugrand, Victor de Ledinghen, Catherine Douvin, Raoul Poupon, Jean-Claude Trinchet, Marianne Ziol, Pierre Bedossa, Patrick Marcellin
Format: Article
Language:English
Published: Elsevier 2015-11-01
Series:Annals of Hepatology
Subjects:
HBV
CAP
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119309512